首页> 外文期刊>Cancer biology & therapy >Stable knockdown of Aurora-A by vector-based RNA interference in human esophageal squamous cell carcinoma cell line inhibits tumor cell proliferation, invasion and enhances apoptosis.
【24h】

Stable knockdown of Aurora-A by vector-based RNA interference in human esophageal squamous cell carcinoma cell line inhibits tumor cell proliferation, invasion and enhances apoptosis.

机译:通过基于矢量的RNA干扰在人食管鳞状细胞癌细胞系中稳定敲低Aurora-A,可抑制肿瘤细胞增殖,侵袭并增强凋亡。

获取原文
获取原文并翻译 | 示例
           

摘要

Esophageal squamous cell carcinoma (ESCC) is one of the most malignant cancers, and the existing treatment approaches have not been able to effectively manage this dreaded cancer. Therefore, continuing efforts are ongoing to explore novel targets and strategies for the management of ESCC. It has been shown that amplification and overexpression of the Aurora-A occur in several types of human tumors, including ESCC. Moreover, overexpression of Aurora-A is shown to associate with the grades of tumor differentiation and metastasis of ESCC. These render Aurora-A an interesting target for antitumor therapy. Recently, vector-based RNA interference (RNAi) expression systems have been successfully used to silence gene expression, but knockdown of Aurora-A by vector-based RNAi as a therapeutic model for ESCC treatment is not fully established. In this study, we used a DNA vector-based RNAi approach by expressing short hairpin RNA (shRNA) to knockdown Aurora-A. Western blotting analysis and reverse transcription PCR (RT-PCR) showed that expressions of Aurora-A were efficiently downregulated at both the protein and mRNA levels by stable transfection with Aurora-A siRNA expression vector. The stable suppression of Aurora-A expression inhibited the proliferation and invasion of EC9706 cells. Furthermore, when Aurora-A was stably downregulated, cisplatin-induced cytotoxic effects and apoptosis were increased dramatically. These data indicate that vector-mediated silencing of the Aurora-A gene may provide new avenues toward the study of the role of Aurora-A overexpression in tumor cells. Make a novel therapeutic approach to treatment of ESCC and other malignant tumors overexpressing Aurora-A.
机译:食道鳞状细胞癌(ESCC)是最恶性的癌症之一,现有的治疗方法还不能有效地治疗这种可怕的癌症。因此,正在进行持续的努力以探索用于ESCC管理的新颖目标和策略。已经显示出Aurora-A的扩增和过表达发生在几种类型的人类肿瘤中,包括ESCC。此外,Aurora-A的过表达与ESCC的肿瘤分化和转移程度有关。这些使Aurora-A成为抗肿瘤治疗的有趣靶标。最近,基于载体的RNA干扰(RNAi)表达系统已成功用于沉默基因表达,但是基于载体的RNAi作为ESCC治疗的治疗模型对Aurora-A的敲低尚未完全建立。在这项研究中,我们通过表达短发夹RNA(shRNA)来敲低Aurora-A,使用了基于DNA载体的RNAi方法。 Western印迹分析和逆转录PCR(RT-PCR)表明,通过Aurora-A siRNA表达载体的稳定转染,Aurora-A的表达在蛋白质和mRNA水平均得到有效下调。稳定地抑制Aurora-A表达抑制了EC9706细胞的增殖和侵袭。此外,当Aurora-A稳定下调时,顺铂诱导的细胞毒性作用和细胞凋亡显着增加。这些数据表明,载体介导的Aurora-A基因沉默可能为研究Aurora-A在肿瘤细胞中过度表达的作用提供新途径。提出一种新的治疗方法,以治疗ESCC和其他过表达Aurora-A的恶性肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号